Bank of America Corporation »

Entrada Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $414k 27k 15.09
2023-09-30 $369k 23k 15.80
2023-06-30 $330k 22k 15.14
2023-03-31 $490k 34k 14.50
2022-12-31 $72k 5.3k 13.52
2022-06-30 $158k 13k 12.16
2021-12-31 $391k 23k 17.12